Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

2015; Springer Science+Business Media; Volume: 151; Issue: 3 Linguagem: Inglês

10.1007/s10549-015-3435-y

ISSN

1573-7217

Autores

Virginia Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Kalliopi P. Siziopikou, Kirsten M. Timms, Alexander Gutin, Victor Abkevich, Zaina Sangale, Cara Solimeno, Krystal Brown, Joshua T. Jones, Anne-Renee Hartman, Caitlin Meservey, Borko Jovanovic, Irene Helenowski, Seema A. Khan, Kevin P. Bethke, Nora Hansen, Regina Uthe, Sara Giordano, Steven T. Rosen, Kent Hoskins, Jamie Von Roenn, Sarika Jain, Vamsi Parini, William J. Gradishar,

Tópico(s)

HER2/EGFR in Cancer Research

Referência(s)